Immunogenomic analyses of advanced serous ovarian cancer reveal immune score is a strong prognostic factor and an indicator of chemo-sensitivity.
CONCLUSIONS: Our results reveal the drivers of the immune repertoire of advanced ovarian cancer and demonstrate the importance of immune score as an independent prognostic signature and a potent indicator of intratumoral immune status.
PMID: 29661778 [PubMed - as supplied by publisher]
Source: Clinical Cancer Research - Category: Cancer & Oncology Authors: Di LJ, Hao D, Liu J, Chen M, Li J, Wang L, Wang G, Zhao Q Tags: Clin Cancer Res Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Genetics | Immunotherapy | Ovarian Cancer | Ovaries